Businesstoday
HOME
ECONOMY
Delhi Metro Phase IV: Centre to share 50% of land cost with Delhi govt
Cabinet approves partial credit guarantee scheme for PSBs to purchase financially sound NBFC assets
7th Pay Commission: Centre approves allowances to 4.5 lakh govt employees in Jammu & Kashmir, Ladakh
Personal Data Protection Bill to burden firms with long-drawn, expensive compliance process
India's copper production shrinks 6.4%; Sterlite Copper, Hindustan Copper see massive slump in output
CORPORATE
Maruti Suzuki teams up with Federal Bank for dealer loans, retail car financing
Facebook, Google no longer among 10 best places to work
Meet N Srinath, the frontrunner for Tata Trusts CEO position
Paytm founder Vijay Shekhar Sharma steps down as Paytm Financial Services director
Piramal Enterprises gets CCI nod for subscription of its debentures by CDPQ
MARKETS
Why CG Power and Industrial Solutions shares fell 5% today
Ujjivan Small Finance Bank to debut on bourses tomorrow; investors likely to gain 50%
Saudi Aramco shares at 10% premium above issue price on listing day
Why YES Bank share price fell nearly 20% in intra day trade
Dish TV share price rises over 8% on report DTH operations may merge with Airtel
MONEY
In era of defaults, diversification can help you secure your FDs
ManipalCigna Health Insurance launches a 'super top-up' plan; should you buy?
Motilal Oswal AMC launches two index funds; should you invest?
Income tax on gifts: Know when your gift is tax-free
Should you go for new auto loan SMART EMI from ICICI Bank?
INDUSTRY
Meet N Srinath, the frontrunner for Tata Trusts CEO position
IndiGo Delhi-Hyderabad flight turns around after mid-air technical alert
After Maruti, Hyundai cars to get expensive from January 2020
General Motors doubling down on SUVs, unveils redesigned Chevy Tahoe, Suburban
Pharma companies giving payouts to doctors, claims All India Drug Action Network
TECH
WhatsApp won't work on these phones from next year; check out list of devices
PUBG Mobile 0.16.0 update rolls out today; all you need to know
Vivo U20 8GB RAM variant launched in India: Check out price, camera, features, offers
Redmi K30 to launch today: Price, specifications, availability
Vivo V17 launched in India: Check out price, camera, other features
OPINION
How Microfinance sector can leverage Big Data analytics for financial inclusion
Australian PM Scott Morrison India visit 2020: An opportunity for both the countries to make synergies work
AI, IoT, blockchain causing fresh threats to cyber security, says Sandeep Gupta of Protiviti
Convenience and cheaper options, why millennials are buying insurance online
Why travel insurance is key to your trips abroad
photos
These will be the top 10 most sought-after jobs in India in 2020
Here are India's 10 best-performing police stations
India ranks 129 out of 189 countries in Human Development Index 2019
Fixing the economy: What Raghuram Rajan wants Modi govt to do
These are the top ten most innovative economies of the world
Videos
02:16
Personal Data Protection Bill: All you need to know
02:23
Saudi Aramco: How it became the most profitable company
01:48
Why video of Abhijit Banerjee and Esther Duflo has gone viral
03:37
Paytm founder resigns as Director, FM opts out of GoM on IGST
05:14
Citizenship Bill passed in Lok Sabha with 311 votes in favour
MAGAZINE
December 15, 2019
December 1, 2019
November 17, 2019
November 3, 2019
October 20, 2019
Settings
Logout
BT SPECIALS
SPECIAL ISSUES
SPECIAL REPORTS
BT BUZZ
SLOWDOWN BLUES
JOBS REALITY CHECK
UNION BUDGET
WORLD ECONOMIC FORUM
LOK SABHA ELECTION 2019
REBRAIN OR ROT
EVENTS
MAGAZINE ARCHIVES
BUSINESS TODAY
BT MORE
MONEY TODAY
GADGETS AND GIZMOS
Home
Search
Total 1166 results found. Search for
[ pharmaceutical companies ]
Results 1120 to 1140 of 1166
Protect or Perish
Shamni Pande
March 5, 2009
In businesses, big or small, ranging from manufacturing to music, the fight for intellectual property is getting intense. Neglect it and you could be out of business.
'The best advice I ever got'
www.businesstoday.in
December 25, 2008
BT asks the who’s who of India’s corporate world—as well as some professionals and leaders from other fields for good measure—to jog their memory and recall the best advice they ever got. What the advice was, who gave it to them and when, and how it helped them.
Starting up all over again
www.businesstoday.in
December 11, 2008
The promoters of Zandu Pharma and Fem Care Pharma recently sold their stakes at attractive valuations. All the deals were struck above the prevailing stock prices of the two companies, an enviable feat considering the depressed economic and market conditions.
The E to Z of Ayurveda
Somnath Dasgupta
December 11, 2008
Will Emami’s acquisition of Zandu Pharma change the landscape of the consumer products sector?
Rocked by the meltdown
Virendra Verma
November 13, 2008
After years of rollicking appreciation, companies that make up the BT 500 are going through one of their toughest phases in a long, long time. As stocks get mercilessly hammered, this may just be the time when the men are separated from the boys. Virendra Verma reports.
Under the scanner
Shalini S. Dagar
October 2, 2008
Ranbaxy gets on the wrong side of regulatory bodies.
Analysing analytics
Tejaswi Shekhawat
September 18, 2008
Analytics empower organisations to stay one step ahead, to out-think and out-execute the competition.
Not Reddy, yet
www.businesstoday.in
August 6, 2008
After Daiichi Sankyo’s purchase of Ranbaxy Labs, Teva Pharma, the world’s largest generics company, acquired Barr Pharma, the US’ fourth largest generics firm. There are two questions on pharma analysts’ lips these days: Who’s next? Are Indian generics players targets for pharma MNCs?
Noted
www.businesstoday.in
July 8, 2008
Risen: By 38.6 per cent, direct tax collections during the first quarter of 2008-09, to Rs 57,373 crore, compared to 28 per cent and Rs 41,391 crore for the corresponding period last year.
From bitter to sweet
E Kumar Sharma
June 25, 2008
A healthy dose of pharma stocks in your portfolio can be a good defensive strategy in this volatile market.
Malvinder's sweet deal
Shalini S. Dagar
June 24, 2008
By selling out to Daiichi Sankyo, the CEO& MD of Ranbaxy hasn’t just netted a Rs 9,576-crore windfall, but brightened the company's future sans him in the global generics' marketplace. A report by Business Today's Shalini S. Dagar. Ranbaxy will continue acquisition, says CEORanbaxy to sell stake to Japan's Daiichi
From the editor: June 29, 2008
Sanjoy Narayan
June 29, 2008
As our cover package points out, the massive subsidies being doled out by the government to shield consumers from high oil prices may actually be compromising the country's long-term ability to sustain high growth rates and also oil conservation efforts.
A deal now come undone
T.V. Mahalingam
June 10, 2008
A year ago in late May 2007, Mumbai-headquartered Sun Pharma, together with its subsidiaries, had signed 'definitive agreements' to acquire Taro Pharmaceutical Industries, a multinational manufacturer of generic pharmaceuticals. A year later, the transaction is in tatters and both parties are washing dirty linen in public. Why? T.V. Mahalingam finds out the reasons.
In choppy waters
Manu Kaushik
June 9, 2008
The market is going through a rough phase as it navigates cross-currents. What should investors do?
Hubs of excellence
www.businesstoday.in
May 28, 2008
The sheer amount of manufacturing activity taking place in small towns of India is mindboggling. Shops are being set up at breakneck speed and there is massive expansion. Where are these clusters located, and can they really deliver on their promise? Here is what Business Today discovered.
April march
E. Kumar Sharma
May 15, 2008
Dr Reddy’s makes three niche acquisitions in 30 days.
Into rainbow country
www.businesstoday.in
May 15, 2008
Over the past 3-4 years, a number of domestic firms have bid for South African companies. Why is India Inc. headed to South Africa?
Prescription for a rewarding career
Manu Kaushik
May 14, 2008
High compensation awaits clinical research professionals.
Nine solid stocks to buy
Rishi Joshi
May 14, 2008
It has been a good recovery for the stock markets so far. Whether stock markets rise or fall, smart money will always chase sound stocks. Here’s what you should keep an eye on.
Taking baby steps into the nano world
Nitya Varadarajan
May 12, 2008
India Inc is waking up to nanotechnology, and this promises to change the way you live—whether by arresting the biological ageing process or curing diseases, such as cancer, diabetes and HIV-AIDS, or even bringing out the best from shampoos and airconditioners. A report by Nitya Varadarajan.
PAGES 57 OF 59
56
57
58
59
Advertisement
LATEST
Must Read
TECH NEWS
What is Citizenship Amendment Bill? Why is it problematic?
Maruti Suzuki teams up with Federal Bank for dealer loans, retail car financing
Delhi Metro Phase IV: Centre to share 50% of land cost with Delhi govt
Citizenship Amendment Bill passed in Rajya Sabha with 125 votes
Biz EOD: Data Protection Bill to burden firms; India's copper output shrinks 6.4%; Big changes likely in GST rates
More
Reliance Jio Prime vs Airtel, Vodafone, Idea 4G offers
Reliance Jio plans to bring 5G internet to your smartphones
Maruti Suzuki opens online booking for Baleno RS
India Inc to get 9.5 per cent salary hike this year
Five tips to get a good salary hike this year
WhatsApp won't work on these phones from next year; check out list of devices
PUBG Mobile 0.16.0 update rolls out today; all you need to know
Vivo U20 8GB RAM variant launched in India: Check out price, camera, features, offers
Redmi K30 to launch today: Price, specifications, availability
Vivo V17 launched in India: Check out price, camera, other features
More